Radial Shockwave for Spasticity in Children With CP or ABI

NCT ID: NCT06909838

Last Updated: 2025-07-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-24

Study Completion Date

2025-06-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to determine if radial Extracorporeal shockwave therapy (rESWT) reduces spasticity in children with Cerbral Palsy (CP) or traumatic brain injury (TBI). The main questions it aims to answer are:

* Is it feasible to implement radial shockwave therapy in conventional physiotherapy plan in children with CP or TBI?
* Is it safe and effective to use rESWT for reducing spasticity in children with CP or TBI? Participants will receive a 4 week therapy intervention, as add on to the conventional physio (usual care), including one rESWT session per week for a total of 4 sessions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spasticity Due to Cerebral Palsy Spasticity Post-Traumatic Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual care

Conventional physiotherapy plan

Group Type ACTIVE_COMPARATOR

Conventional treatment

Intervention Type OTHER

Usual conventional therapy, including physiotherapy, ergotherapy, hippotherapy,..

Shockwave and usual care

All participants receive a 4-week rESWT intervention plan (4 sessions with a one week interval), as add-on to the conventional physiotherapy plan

Group Type EXPERIMENTAL

radial Extracorporeal shockwave therapy (rESWT)

Intervention Type DEVICE

4 rESWT interventions, with a one week interval, are added to the conventional treatment plan

Conventional treatment

Intervention Type OTHER

Usual conventional therapy, including physiotherapy, ergotherapy, hippotherapy,..

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

radial Extracorporeal shockwave therapy (rESWT)

4 rESWT interventions, with a one week interval, are added to the conventional treatment plan

Intervention Type DEVICE

Conventional treatment

Usual conventional therapy, including physiotherapy, ergotherapy, hippotherapy,..

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* cerebral palsy or acquired brain injury
* between 6-18 years old;
* gross motor function classification ≥2;
* experiencing spasticity in the lower limb (calf muscles, hip adductor muscles or hamstring muscles) and/or in the upper limb (biceps muscle, wrist flexor muscles, finger flexor muscles) with Modified Ashworth Scores (MAS) ≥1+.

Exclusion Criteria

* recent (≤3 months) Botox injections or other recent (≤6 months) invasive intervention;
* local infections or wounds; neuropathy;
* severe organ dysfunction;
* severe psychosocial dysfunction that would not allow adhering to protocol;
* planned changes in medication dosage or medication scheme that might affect spasticity during a 4-month intervention and follow-up phase.
Minimum Eligible Age

6 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

FRAME Jessa Ziekenhuis, Belgium

UNKNOWN

Sponsor Role collaborator

Gymna Uniphy

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Aerssens, Pediatrician

Role: PRINCIPAL_INVESTIGATOR

MFC Sint Gerardus

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sint-Gerardus

Diepenbeek, Limburg, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S68824

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.